Back to announcement
20240913_SCPI_Tanggapan atas Permintaan Penjelasan Bursa_31725980_lamp3.pdf
Other Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 11
Page 1
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
No. 099/OPI/IX/2024 Jakarta, 13 September 2024
Kepada Yth./ To:
Bursa Efek Indonesia / Indonesia Stock Exchange (“BEI”)
Indonesia Stock Exchange Building,
Tower I, 6th Floor,
Jl. Jend. Sudirman Kav.52-53, Jakarta 12190 – Indonesia
U.p./Attn: Kepala Divisi Penilaian Perusahaan 3 / Head of Company Assessment Division 3
Perihal: Penyampaian Tanggapan atas Surat Subject: Response Submission to BEI’s Letter
BEI sehubungan dengan Permintaan concerning Request for Explanation of PT
Penjelasan PT Organon Pharma Indonesia Tbk Organon Pharma Indonesia Tbk
Dengan hormat, Dear Sir/Madam,
Merujuk surat BEI No. S-09297/BEI.PP3/09-2024 Referring to BEI’s letter No. S-09297/BEI.PP3/09-
tanggal 3 September 2024 tentang Permintaan 2024 dated 3 September 2024 regarding Request
Penjelasan PT Organon Pharma Indonesia Tbk for Explanation of PT Organon Pharma Indonesia
(“Surat BEI”) yang ditujukan kepada PT Organon Tbk (“BEI’s Letter”) addressed to PT Organon
Pharma Indonesia Tbk (“Perseroan”), bersama Pharma Indonesia Tbk (“Company”), with this
dengan surat ini Perseroan bermaksud untuk letter the Company intends to submit the
memberikan beberapa tanggapan atas Surat BEI explanation to the pertaining BEI’s letter.
tersebut.
Adapun yang dapat kami berikan klarifikasi saat ini At this point of time, Company will give clarification
: for;
1. Kondisi Perseroan Saat Ini 1. Company Current Situation
a. Saat ini Perseroan mengelola dua a. At this point of time, The Company
segmen, yaitu manufaktur dan produk manages 2 business segments,
komersial. namely manufacturing and
i. Manufaktur : Segmen manufaktur commercial pharmaceutical products.
saat ini sebagai kontributor utama i. Manufactur : Currently manufactur
Perseroan. segment is a main contributor for
ii. Komersial : Segmen komersial the Company
sebagai pendukung bagi Perseroan ii. Commercial : Commercial segment
is a proponent for a Company
b. Kapasitas Produksi b. Production Capacity
c. Fokus dan Strategi Perseroan saat ini c. Focus and Company Strategic
Page 2
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
i. Menyerap permintaan yang i. Absorb increasing demand without
meningkat, tanpa ada masalah pada any supply problems, through
pasokan. Melalui optimasi optimizing raw material supplies
persediaan bahan baku ii. Cost efficiency through process
ii. Efisiensi biaya melalui optimasi dan optimization and systematization,
sistematisasi proses serta while also increasing the number of
peningkatan jumlah spesialis QA. QA specialists
iii. Peningkatan akurasi dan efisiensi iii. Increased accuracy and efficiency of
proses ekspor impor the import export process
iv. Simplifikasi proses pelaporan data iv. Simplification of the data reporting
yang berhilir pada kepatuhan process, leading to better and faster
terhadap peraturan yang lebih baik regulatory compliance
dan cepat
d. Strategi pengembangan yang akan d. Development strategy that will be
dilakukan Perseroan carried out by the Company
i. Perseroan berkomitmen untuk i. The Company committed to ensure
memastikan strategi perusahaan the current strategy is well
saat ini dilakukan dengan baik implemented.
2. Kondisi Keuangan dan Penyajian Laporan 2. Financial Condition and Submission of
Keuangan Financial Reports
a. Informasi mengenai tiga komponen a. Information of three main components
utama atas aset lancar dan masing- on current assets and balance as of
masing saldo per 30 Juni 2024 Jun, 30th 2024
Keterangan Jumlah Keterangan Jumlah
Prepaid Exp - Exposed - FX 614,032,565 Prepaid Exp - Exposed - FX 614,032,565
Prepaid Exp - Insurance - General 3,094,974,885 Prepaid Exp - Insurance - General 3,094,974,885
b. Informasi mengenai rincian per b. Information regarding details per
pemasok atas uang muka perolehan supplier of advances for the acquisition
aset tetap per 30 Juni 2024 beserta of fixed assets as of 30 June 2024
jenis aset tetap yang akan dibeli along with the types of fixed assets to
be purchased
Keterangan Jumlah Keterangan Jumlah
Down Payment Pembelian Mesin 11,755,655,109 Down Payment Pembelian Mesin 11,755,655,109
Down Payment Pembelian Alat Lab 430,125,000 Down Payment Pembelian Alat Lab 430,125,000
c. Sehubungan dengan aset hak guna c. In connection with the Company's
Perseroan right-of-use assets
i. Transaksi yang menyebabkan i. Transactions that cause the
timbulnya aset hak guna Company's right-to-use assets
Perseroan – Sewa Gedung to arise – building rent
d. Sehubungan dengan CALK 6 tentang d. In connection with CALK 6, regarding
piutang usaha the trade receivables
i. Memonitor status piutang i. Periodically monitoring the
secara berkala receivable account
ii. Melakukan follow up atas ii. Follow up for the due
piutang yang sudah jatuh receivable account
tempo
Page 3
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
e. Transactions that cause other
e. Transaksi yang menyebabkan receivables to arise
timbulnya piutang lain-lain i. Reimbursement and
i. Pengembalian dan jasa management fee
management ii. The receivable term is 90 days
ii. Jangka waktu piutang 90 hari and interest is 1% per month on
dan bunga 1% per bulan atas the outstanding balance
saldo terhutang f. In Connection with CALK 7 regarding
f. Sehubungan dengan CALK 7 tentang supply
persediaan i. Information of management
i. Informasi mengenai strategi strategy for Company supply -
manajemen persediaan Management registered
Perseroan – Managemen insurance against earthquake
mendaftarkan asuransi risks and other risks on 31 Dec
terhadap risiko gempa bumi 2023 and 30 June 2024. Apart
dan risiko lainnya pada 31 Dec from that, none of the inventory
2023 dan 30 Juni 2024. Selain owned by the Company is used
itu persediaan yang dimiliki as collateral
Perseroan tidak ada yang ii. Justification background – please
dijadikan jaminan. refer to page 32 of Q2 financial
ii. Latar belakang justifikasi – statement
mengacu pada hal 32 laporan iii. Types of inventory experiencing
keuangan Q2 2024 impairment along with details of
iii. Jenis persediaan yang their value – some slow moving
mengalami penurunan nilai products relate to contraceptive
beserta rincian nilainya – products, the company is not sure
beberapa product slow moving the product will be sold
berkaitan dengan produk iv. Current condition of inventory
kontrasepsi, perusahaan tidak which has experienced a decline
yakin produk akan terjual in value - the Company will carry
iv. Kondisi terkini atas persediaan out destruction
yang mengalami penurunan v. The Company's strategy in
nilai tersebut – Perseroan managing and determining the
akan melakukan pemusnahan amount of inventory of raw
v. Strategi Perseroan dalam materials and finished goods –
mengelola dan menentukan The Company will use short term
jumlah persediaan bahan forecast ( 3 – 6 month)
baku dan barang jadi – vi. The Company's inventory storage
Perseroan akan melakukan strategy ensures that product
estimasi berdasarkan jangka quality is maintained – The
pendek ( 3 – 6 bulan) Company will monitor the storage
vi. Strategi penyimpanan temperature, cleanliness, quality
persediaan Perseroan agar inspection to ensure all products
kualitas produk tetap terjaga – based on SOP
Perseroan akan memonitor
suhu, kebersihan tempat
penyimpanan dan melakukan
inspeksi untuk memastikan
produk sesuai SOP.
Page 4
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
vii. Latar belakang dan vii. Background and causes of the
penyebab provisi provision for allowance for
penyisihan penurunan decline in inventory value as of
atas nilai persediaan per 30 June 2024 has increased
30 Juni 2024 mengalami significantly compared to 31
kenaikan signifikan December 2023 - Due to the
dibandingkan per 31 existence of slow moving
Desember 2023 – products.
Dikarenakan adanya viii. Background and causes of a
produk slow moving significant increase in the
viii. Latar belakang dan Company's raw material
penyebab terdapat inventory as of 30 June 2024
kenaikan signifikan pada compared to 31 December 2023
persediaan bahan baku - The Company will adjust
Perseroan per 30 Juni production planning in the 3rd
2024 dibandingkan per 31 quarter
Desember 2023 – g. In connection with CALK 8 about
Perseroan akan current asset, pelase elaborate:
menyesuaikan dengan
perencanaan produksi di i. Information regarding the
kuartal 3 Company's fixed assets
that have been fully
g. Sehubungan dengan CALK 8 depreciated – The
tentang aset tetap, agar dijelaskan: Company owns the IPT A
i. Informasi mengenai aset factory building
tetap Perseroan yang ii. Information regarding the
telah terdepresiasi current condition of the
penuh – Perseroan Company's fixed assets
memiliki bangunan which have been fully
pabrik IPT A depreciated and their use
ii. Informasi mengenai for the Company's
kondisi terkini atas aset operations - The building
tetap Perseroan yang is still used for production
telah terdepresiasi activities and is still in very
penuh beserta good condition
penggunannya untuk iii. Background to
operasional Perseroan - management's justification
Bangunan masih di in determining that there is
gunakan untuk aktivitas no decline in the value of
produksi dan masih fixed assets as of 30 June
dalam kondisi yang 2024 and as of 31
sangat baik December 2023 –
iii. Latar belakang justifikasi Referring to the Q2 2024
manajemen dalam financial report page 19
menentukan tidak
adanya penurunan nilai
aset tetap per 30 Juni
2024 dan per 31
Desember 2023 –
Mengacu pada laporan
keuangan Q2 2024
halaman 19.
Page 5
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
h. Sehubungan dengan CALK 9 h. In connection with CALK 9
tentang usaha, agar dijelaskan regarding business, the
strategi Perseroan agar dapat Company's strategy should be
melakukan pembayaran utang explained so that it can pay
usaha sesuai dengan jangka waktu business debts according to the
yang telah ditentukan – predetermined time period - The
Perusahaan membuat company makes a cash flow plan,
perencanaan cashflow, analyzes AP aging, adjusts the
menganalisa AP aging, debt payment period to the vendor.
menyesuaikan jangka waktu i. In connection with CALK 10
pembayaran hutang ke vendor regarding accruals, please explain
i. Sehubungan dengan CALK 10 i. Transactions that result
tentang akrual, agar dijelaskan in the accrual of goods in
i. Transaksi yang transit amounting to IDR
menyebabkan timbulnya 119.61 billion as of 30
akrual barang dalam June 2024 - Because
perjalanan sebesar using FCA incoterms
Rp119,61 miliar per 30 where goods have left
Juni 2024 - Karena the seller's warehouse
menggunakan incoterms (intercompany) can
FCA dimana barang sudah already be recognized
keluar dari gudang penjual as good in transit
( intercompany ) sudah ii. Details regarding
bisa di akui sebagai good professional services
in transit and their parties
ii. Rincian mengenai jasa regarding the accrual of
profesional beserta professional services as
pihaknya atas akrual jasa of 30 June 2024 – Jasa
profesional per 30 Juni Professional.
2024 – Jasa Professional j. Regarding other debts, please
j. Sehubungan dengan utang lain- explain
lain, agar dijelaskan: i. Transactions that cause
i. Transaksi yang other debts to arise –
menyebabkan timbulnya Payment of dividends
utang lain-lain – and third party financing
Pembayaran deviden dan that is not related to
pembiayaan pihak ketiga production
yang tidak terkait dengan ii. Information regarding
produksi. the term and interest
ii. Informasi mengenai charged on the
jangka waktu dan Company's other debts –
pengenaan bunga atas 60 to 90 days
utang lain-lain Perseroan – iii. Background and causes
60 s.d 90 hari of the Company's
iii. Latar belakang dan dividend debt - This is
penyebab adanya utang because there are
dividen Perseroan - Hal ini individual shareholders
di karenakan ada nya who have not disbursed
pemegang saham their dividends to PT
perorangan yang belum Organon
melakukan pencairan
dividen nya kepada PT
Organon
Page 6
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
k. Informasi mengenai transaksi yang k. Information regarding transactions
menyebabkan timbulnya liabilitas that give rise to rental liabilities - PT
sewa - Sewa Gedung PT Organon Organon Pharma Indonesia
Pharma Indonesia Building Lease
l. Sehubungan dengan liabilitas l. In relation to post-employment
imbalan pascakerja, agar benefit obligations, please explain:
dijelaskan: i. Background and causes of
i. Latar belakang dan the increase in post-
penyebab terjadinya employment benefits
kenaikan liabilitas liabilities as of 30 June
imbalan pascakerja per 2024 compared to 31
30 Juni 2024 December 2023 - Due to
dibandingkan per 31 an increase in length of
Desember 2023 - service and an increase in
Karena adanya annual salary
peningkatan masa kerja ii. The Company's internal
dan kenaikan gaji party that calculates the
tahunan value of post-employment
ii. Pihak internal Perseroan benefits liabilities - Santhi
yang melakukan Devi and Ardianto
penghitungan nilai Handoyo Actuarial
liabilitas imbalan Consultant Office
pascakerja - Kantor m. In connection with CALK 19
Konsultan Aktuaria regarding income, please explain:
Santhi Devi dan Ardianto
Handoyo i. Information regarding
products sold to related
m. Sehubungan dengan CALK 19 parties of the Company -
tentang pendapatan, agar The Company sells
dijelaskan: Cardiovascular, Derma,
i. Informasi mengenai Respi, Pain products
produk yang dijual ii. Background and causes of
kepada pihak berelasi the increase in the
Perseroan – Perseroan Company's revenue -
menjual produk There is increasing
Cardiovascular, Derma, demand from Asia Pacific
Respi, Pain
iii. The company must
ii. Latar belakang dan provide information on the
penyebab terjadi average number of goods
kenaikan pendapatan sold for revenue ending on
Perseroan – Adanya June 30, 2024 and 2023 –
permintaan yang 929,000 packs in 2023 and
meningkat dari Asia 945,000 packs in 2024
Pasifik
iv. The Company's strategy
iii. Perseroan agar and efforts to increase the
menyampaikan Company's income - the
informasi rata-rata Company is expanding the
jumlah barang yang domestic and export
dijual atas pendapatan markets for the company's
yang berakhir pada per superior products
30 Juni 2024 dan 2023 –
929,000 pack pada
tahun 2023 dan 945,000
pack di tahun 2024
Page 7
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
iv. Strategi dan upaya v. Information regarding
Perseroan untuk products that provide the
meningkatkan pendapatan highest contribution to the
Perseroan – Perseroan Company's revenue -
melakukan ekspansi pasar Cardiovascular,
domestik dan ekspor, Respiratory, Pain, Bone
untuk produk2 unggulan and Dermatology Products
perushaan vi. Background and causes of
v. Informasi mengenai sales returns and
produk yang memberikan discounts for the period 30
kontribusi tertinggi pada June 2024 have increased
pendapatan Perseroan - compared to 30 June 2023
Produk Cardiovascular, - more sales to customers
Respiratory, Pain, Bone
and Dermatology
vi. Latar belakang dan
penyebab retur dan diskon
penjualan periode 30 Juni
2024 mengalami kenaikan
dibandingkan 30 Juni 2023
– sales yang lebih banyak
ke customer
n. Sehubungan dengan CALK 20 n. In connection with CALK 20
tentang beban pokok pendapatan,
regarding cost of income, please
agar dijelaskan;
explain;
i. Latar belakang dan
i. Background and cause
penyebab beban pokok of the cost of revenue for
pendapatan periode 30
the period 30 June 2024
Juni 2024 mengalami
has increased compared
kenaikan dibandingkan
to the period 30 June
periode 30 Juni 2023 –
2023 - Due to an
Karena terjadinya
increase in raw materials
kenaikan bahan baku
ii. Background and
ii. Latar belakang dan alasan
reasons for the increase
pembelian bahan baku
in raw material
periode 30 Juni 2024
purchases for the period
mengalami kenaikan 30 June 2024 compared
dibandingkan periode 30
to the period 30 June
Juni 2023 - Menyesuaikan
2023 - Adjusting to
dengan perencanaan
production planning in
produksi di kwartal 3
the 3rd quarter
iii. Latar belakang dan alasan
iii. Background and
biaya pabrikasi periode 30
reasons for
Juni 2024 mengalami
manufacturing costs for
penurunan dibandingkan
the period 30 June 2024
periode 30 Juni 2023 -
decreased compared to
Karena ada nya the period 30 June 2023
penambahan beban biaya
- Due to additional costs
untuk produksi bahan jadi
for the production of
untuk customer pihak
finished materials for
ketiga di semester 1- 2023
third party customers in
semester 1-2023
Page 8
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
iv. Latar belakang dan iv. Background and reasons
alasan pembelian for purchases of finished
barang jadi periode 30 goods for the period 30
Juni 2024 mengalami June 2024 have increased
kenaikan dibandingkan compared to the period 30
periode 30 Juni 2023 - June 2023 - More goods
Barang di produksi lebih are produced due to
banyak karena market demand
permintaan pasar v. The background and
v. Latar belakang dan reasons for writing off
alasan penghapusan finished goods for the
barang jadi periode 30 period 30 June 2024 have
Juni 2024 mengalami increased compared to the
kenaikan dibandingkan period 30 June 2023 -
periode 30 Juni 2023 - Because inventory
Karena bahan materials can no longer be
persediaan sudah tidak used for the production
bisa di gunakan untuk process
proses produksi o. In connection with CALK 18
o. Sehubungan dengan CALK 18 regarding other income, please
tentang penghasilan lain-lain, agar explain:
dijelaskan: i. Information regarding
i. Informasi mengenai jasa management services
manajemen yang provided by the Company
diberikan oleh for management services
Perseroan atas income of IDR 5.52 billion
pendapatan jasa for the period 30 June
manajemen sebesar 2024 – Management
Rp5,52 miliar untuk Services
periode 30 Juni 2024 – ii. Background and causes of
Jasa Manajemen management services for
ii. Latar belakang dan the period 30 June 2024
penyebab jasa have increased compared
manajemen periode 30 to the period 30 June 2023
Juni 2024 mengalami - Due to the increase in
kenaikan dibandingkan research and development
periode 30 Juni 2023- services, general services
Karena meningkatnya and promotions
layanan penelitian dan p. In connection with CALK 20
pengembangan, jasa regarding taxation, please explain;
umum dan promosi
i. Transactions that cause
p. Sehubungan dengan CALK 20 prepaid tax to arise on
tentang perpajakan, agar corporate income tax - Due
dijelaskan; to the position of CIT
i. Transaksi yang Calculation in Q2'2024 is
menyebabkan timbulnya overpayment
pajak dibayar di muka ii. Transactions that cause
atas pajak penghasilan prepaid tax to arise on
badan - Di karenakan value added tax – Higher
posisi CIT Calculation vendor transactions
pada saat Q2'2024
adalah overpayment
Page 9
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
ii. Transaksi yang iii. Transactions that cause
menyebabkan timbulnya prepaid tax to arise on
pajak dibayar di muka atas income tax article 22 –
pajak pertambahan nilai – None
Transaksi vendor yang iv. Information regarding the
lebih tinggi process or submission of
iii. Transaksi yang refunds for the Company's
menyebabkan timbulnya prepaid taxes - Refer to
pajak dibayar di muka atas Q2'2024 financial report
pajak penghasilan pasal page 44.
22 – Tidak Ada v. Background and reasons
iv. Informasi mengenai for the Company not
proses atau pengajuan recording income tax debt
restitusi atas pajak dibayar article 25 - The current tax
di muka Perseroan - Refer position for PT Organon is
pada laporan keuangan overpayment so it does not
Q2'2024 halaman 44 record income tax article
v. Latar belakang dan 25
penyebab Perseroan tidak
membukukan utang pajak
penghasilan pasal 25 -
Posisi pajak saat ini untuk
PT Organon adalah lebih
bayar sehingga tidak
membukukan pajak
penghasilan pasal 25
q. Sehubungan dengan laporan arus q. In connection with the Company's
kas Perseroan, agar dijelaskan: cash flow report, please explain;
i. Latar belakang dan i. Background and causes
penyebab terjadinya of the increase in cash
kenaikan penerimaan kas receipts from customers
dari pelanggan untuk for the period 30 June
periode 30 Juni 2024 2024 compared to the
dibandingkan periode 30 period 30 June 2023 -
Juni 2023 - Terjadi nya There was an increase in
peningkatan revenue revenue
ii. Latar belakang dan ii. Background and causes
penyebab penerimaan of tax refund receipts for
restitusi pajak periode 30 the period 30 June 2024
Juni 2024 lebih kecil being smaller than for
dibandingkan periode 30 the period 30 June 2023
Juni 2023 – Pada juni 2023 - In June 2023 the
Perseroan menggunakan Company used annual
restitusi tahunan, sedang refunds, while in 2024
pada 2024 Perseroan the Company has
sudah mulai mencicil started paying in
setiap period dimana tiap 3 installments every 3
bulan months
Page 10
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
3. Perkembangan proses Voluntary Delisting 3. Update on the Voluntary Delisting or Go
dan Go Private Perseroan - Saat ini jumlah Private - As of now, the number of
pemegang saham belum memenuhi Company’s shareholders has not yet met
minimal kuota ambang batas yang the required threshold to proceed with the
dipersyaratkan untuk melanjutkan application for the withdrawal of the effective
permohonan pencabutan surat efektif dari letter from OJK. Therefore, Company is
OJK. Perseroan sedang merumuskan currently working on formulating alternative
pendekatan alternatif untuk memenuhi approaches to meet the applicable
persyaratan yang berlaku. requirements.
4. Informasi Struktur Pemegang Saham dan 4. Information on Shareholder Structure and
Laporan Bulanan Registrasi Pemegang Monthly Securities Holder Registration
Efek : Report
Item Jumlah
Saham Perseroan dalam bentuk warkat 37,800
Saham Perseroan dalam bentuk scripless 3,562,200
Saham Perseroan dalam bentuk scripless < 5% 5,864
Jumlah pemegang saham perseroan 437
Jumlah pemegang yang memiliki saham warkat 421
Jumlah pemegang saham SID 437
Jumlah saham free float 5,864
5. Informasi Lainnya 5. Other information
a. Konfirmasi mengenai perubahan a. Confirmation regarding changes to
susunan komite audit Perseroan – the composition of the Company's
Perubahan susunan komite audit audit committee - Changes to the
Perseroan per tanggal 1 Juni 2024 composition of the Company's audit
b. Rencana tindakan korporasi dalam committee as of June 1 2024
12 kedepan – Tidak ada b. Corporate action plans in the next
c. Informasi/kejadian penting lainnya 12 years – None
yang material dan dapat c. Other important information/events
mempengaruhi kelangsungan that are material and can affect the
hidup perusahaan serta dapat survival of the company and can
mempengaruhi harga saham affect the Company's share price –
Perusahaan – Tidak Ada None
Page 11
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
Hormat Kami/Best Regards,
PT Organon Pharma Indonesia Tbk
Nama/Name: Daniel
Jabatan/Title: President Director
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Indonesia Stock Exchange
p.1 ×2
unresolved
org
Pharma Indonesia Tbk
p.1
unresolved
person
Nama/Name: Daniel
· Jabatan/Title: President Director
p.11
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.